The Financial Times pointed to “significant investor opposition” to the suggested selloff, with the floated price tag driving much of the pushback. A “top 10 investor” communicated that the sale “‘might make sense’” if the involved value was 30 percent higher and touched upon a perceived lack of transparency concerning transactional costs, according to the report. “‘I’d be stunned if it doesn’t get voted down,’” another shareholder summed up of the possible $440 million sale.
Source: Hipgnosis Shareholders Reportedly Oppose $440M Catalogs Sale